Compass Therapeutics, Inc.

US$0.76As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:CMPXHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (33.11%)
Div yield —
ROE (56.66%)
Biotechnology
Beta (5Y) 1.06
PE TTM —
TSR TTM (79.71%)
Mkt cap US$136.7M
ROIC (36.36%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.86
13.39%
(46.41%)
Hold 11|7|10|2|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.02
0.02
21.36%
22.90%
33.06%
33.95%
Revenue$M
5.391
5.292
5.594
5.849
(8.49%)
(7.48%)
0.68%
5.61%
Peers (US$136.7M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.057
0.078
0.082
EBIT/Intx
1.760
0.314
0.329
Own earn%
67.05
(53.07)
(44.00)
Sh yield%
51.65
28.48
28.59
Owners
Insiders/Inst%
12.26
39.48
Short interest%
4.55
SBC / revenue%
1.15
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
26–31
$1 testx
—
Incr. ROIC%
3